OTC Medication Information: SENNA-S

SENNA-S- docusate sodium and sennosides tablet, film coated
Strategic Sourcing Services, LLC

Drug Facts

Active ingredients (in each tablet) Docusate sodium 50 mg Sennosides 8.6 mg

Purpose Stool Softner Laxative

Uses • relieves occasional constipation (irregularity) • generally produces bowel movement in 6-12 hours

Warnings Do not use • If you are now taking mineral oil, unless directed by a doctor • laxative products for longer than 1 week, unless directed by a doctor

Ask a doctor before use if you have • stomach pain • nausea • vomiting • noticed a sudden change in bowel habits that lasts over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding , ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away 1(800)222-1222

Directions • take preferably at bedtime or as directed by a doctor
Age Starting Dosage Maximum Dosage adults and children 12 years of age or over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Other informationeach tablet contains: calcium 20 mg, sodium 6 mg • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients: carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dicalcium phosphate, D&C yellow No. 10, FD&C Yellow No. 6, hypromellose, magnesium stearate, microcrystalline cellulose, maltodextrin, polyethylene glycol, purified water, sodium benzoate, stearic acid, titanium dioxide

Questions or comments? 1-888-358-6431

PRINCIPAL DISPLAY PANEL

//otclabels.com/lib/images-otc/senna-s-40/sustain_senna-s-300x231.jpg
(click image for full-size original)

SENNA-S
docusate sodium and sennosides tablet, film coated
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:70677-1246
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM 50 mg
SENNOSIDES (SENNOSIDES) SENNOSIDES 8.6 mg
Inactive Ingredients
Ingredient Name Strength
CARNAUBA WAX
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
D&C YELLOW NO. 10
FD&C YELLOW NO. 6
HYPROMELLOSES
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
MALTODEXTRIN
POLYETHYLENE GLYCOL, UNSPECIFIED
WATER
SODIUM BENZOATE
STEARIC ACID
TITANIUM DIOXIDE
Product Characteristics
Color orange Score no score
Shape ROUND Size 10mm
Flavor Imprint Code S;35
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70677-1246-1 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC Monograph Drug M007 02/02/2024
Labeler — Strategic Sourcing Services, LLC (116956644)

Revised: 02/2024 Strategic Sourcing Services, LLC

Our database comes directly from the FDA’s central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA’s repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.